​

DataMEDS AI (MEDS) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

DataMEDS AI Revenue Highlights

Latest Revenue (Y)

$23.34M

Latest Revenue (Q)

$1.78M

Main Segment (Y)

Product

DataMEDS AI Revenue by Period

DataMEDS AI Revenue by Year

DateRevenueChange
2025-12-31$23.34M28.73%
2024-12-31$18.13M100.00%
2023-12-31--100.00%
2022-12-31$32.78M-

DataMEDS AI generated $23.34M in revenue during NA 2025, up 28.73% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

DataMEDS AI Revenue by Quarter

DateRevenueChange
2026-06-30$1.78M14.13%
2026-03-31$1.56M-6.65%
2025-12-31$1.67M-44.55%
2025-09-30$3.01M-61.33%
2025-06-30$7.79M-28.28%
2025-03-31$10.86M-167.69%
2024-12-31$-16.05M-201.56%
2024-09-30$15.80M51.40%
2024-06-30$10.44M31.47%
2024-03-31$7.94M-76.90%
2023-12-31$34.37M100.00%
2023-09-30-100.00%
2023-06-30--

DataMEDS AI generated $1.78M in revenue during Q2 2026, up 14.13% compared to the previous quarter, and up 16.38% compared to the same period a year ago.

DataMEDS AI Revenue Breakdown

DataMEDS AI Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Product$21.87M$17.67M

DataMEDS AI's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25
Product$1.01M$2.64M$7.55M$10.67M

DataMEDS AI's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).

DataMEDS AI Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDSXBiodesix$88.50M$26.86M
TELATELA Bio$80.28M$19.29M
XLOXilio Therapeutics$43.77M$18.69M
MRSNMersana Therapeutics$40.50M$11.01M
MEDSDataMEDS AI$23.34M$1.78M
INMBINmune Bio$14.00K-
OKUROnKure Therapeutics--
BEATHeartBeam--
ALGSAligos Therapeutics-$27.78M

MEDS Revenue FAQ

What is DataMEDS AI’s yearly revenue?

DataMEDS AI's yearly revenue for 2025 was $23.34M, representing an increase of 28.73% compared to 2024. The company's yearly revenue for 2024 was $18.13M, representing an increase of 100.00% compared to 2023. MEDS's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022.

What is DataMEDS AI’s quarterly revenue?

DataMEDS AI's quarterly revenue for Q2 2026 was $1.78M, a 14.13% increase from the previous quarter (Q1 2026), and a -77.15% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $1.56M, a -6.65% decrease from the previous quarter (Q4 2025), and a -85.64% decrease year-over-year (Q1 2025). MEDS's quarterly revenue for Q4 2025 was $1.67M, a -44.55% decrease from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is DataMEDS AI’s revenue growth rate?

DataMEDS AI's revenue growth rate for the last 3 years (2023-2025) was 0%

What are DataMEDS AI’s revenue streams?

DataMEDS AI's revenue streams in c 25 are Product

What is DataMEDS AI’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of DataMEDS AI was Product. This segment made a revenue of $21.87M, representing 100.00% of the company's total revenue.